Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

French hospital pilots early discharge for new moms with home midwife support

NCT ID NCT05438004

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new care plan for 100 low-risk mothers and their newborns, allowing them to go home within 24 hours after a normal vaginal delivery. Participants received daily visits from a midwife for the first three days and used a special mobile app to stay in touch with the hospital. The goal was to see if this early discharge plan could meet safety recommendations while giving women more choice in their postpartum care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

100 people

The number who actually took part.

Started

Dec 2021

Finished

Mar 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Maternal: * Voluntary * Legal age * Vaginal delivery * General Health Insurance Plan * Accompanying person present at discharge and every day during the first 2 days * Pain VAS \< 5 with or without simple analgesics * Mother-child interaction judged satisfactory by the team * Signature of consent * Pediatric : * Singleton * \> 38 weeks of amenorrhea * Eutrophic * Apgar \> 7 at 5 minutes of life * Respiratory rate \< 60/min; 90bpm \< Heart rate \< 170bpm; SaO2 \>95 * Axillary temperature between 36 and 37°C * Feeding established * Vitamin K1 given * Neonatal screenings organized Exclusion Criteria: * Maternal: * Social isolation, psychiatric disorder with impact on infant care, moderate to severe (according to DSM5) substance use disorder * Poorly balanced chronic condition requiring hospitalization * Postpartum complications requiring hospitalization * Postpartum hemorrhage \> 500mL * Body temperature \> 38.0°C without paracetamol * Thromboembolic signs: pain, edema, positive Homans sign * Protected persons defined in the following articles of the public health code: L. 1121-6: persons deprived of liberty by a judicial or administrative decision, persons hospitalized without consent and persons admitted to a health or social institution for purposes other than research; L. 1121-8: adults subject to a legal protection measure or unable to express their consent; L. 1122-1-2: persons in emergency situations unable to give prior consent. * Pediatric : * Jaundice * Risk factor for neonatal infection (maternal streptococcal B colonization during the current pregnancy, history of neonatal streptococcal B infection in a previous pregnancy, duration of rupture of membranes \> 12 hours, maternal temperature \> 38.0°C intrapartum or during the 2 hours following delivery).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pregnancy related are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hôpital Archet

    Nice, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.